Log in to save to my catalogue

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatm...

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68431566

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance

About this item

Full title

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2005-08, Vol.6 (8), p.589-598

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Cervical cancer is the most common gynaecological malignant disorder worldwide. The best possible treatment of locally advanced cervical cancer is a combination of radiation and cisplatin-based chemotherapy. However, 5-year overall survival is still only 52%. To improve treatment results, research should focus on the discovery of innovative drug st...

Alternative Titles

Full title

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68431566

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68431566

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(05)70281-3

How to access this item